Carole Ben-maimon - Net Worth and Insider Trading
Carole Ben-maimon Net Worth
The estimated net worth of Carole Ben-maimon is at least $2 Million dollars as of 2024-04-27. Carole Ben-maimon is the President and CEO of Larimar Therapeutics Inc and owns about 266,829 shares of Larimar Therapeutics Inc (LRMR) stock worth over $2 Million. Carole Ben-maimon is also the Director of Teligent Inc and owns about 1,600 shares of Teligent Inc (TLGTQ) stock worth over $0. Details can be seen in Carole Ben-maimon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Carole Ben-maimon has not made any transactions after 2023-05-17 and currently still holds the listed stock(s).
Transaction Summary of Carole Ben-maimon
Carole Ben-maimon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carole Ben-maimon owns 2 companies in total, including Larimar Therapeutics Inc (LRMR) , and Teligent Inc (TLGTQ) .
Click here to see the complete history of Carole Ben-maimon’s form 4 insider trades.
Insider Ownership Summary of Carole Ben-maimon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LRMR | Larimar Therapeutics Inc | 2023-05-17 | director & President and CEO |
| TLGTQ | Teligent Inc | 2021-01-04 | director |
Carole Ben-maimon Latest Holdings Summary
Carole Ben-maimon currently owns a total of 2 stocks. Among these stocks, Carole Ben-maimon owns 266,829 shares of Larimar Therapeutics Inc (LRMR) as of May 17, 2023, with a value of $2 Million and a weighting of 100%. Carole Ben-maimon also owns 1,600 shares of Teligent Inc (TLGTQ) as of May 30, 2019, with a value of $0 and a weighting of 0%.
Latest Holdings of Carole Ben-maimon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LRMR | Larimar Therapeutics Inc | 2023-05-17 | 266,829 | 6.44 | 1,718,379 |
| TLGTQ | Teligent Inc | 2019-05-30 | 1,600 | 0.00 | 0 |
Holding Weightings of Carole Ben-maimon
Carole Ben-maimon Form 4 Trading Tracker
According to the SEC Form 4 filings, Carole Ben-maimon has made a total of 2 transactions in Larimar Therapeutics Inc (LRMR) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Larimar Therapeutics Inc is the acquisition of 5,000 shares on May 17, 2023, which cost Carole Ben-maimon around $18,550.
According to the SEC Form 4 filings, Carole Ben-maimon has made a total of 1 transactions in Teligent Inc (TLGTQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Teligent Inc is the acquisition of 1,000 shares on May 30, 2019, which cost Carole Ben-maimon around $5,900.
Insider Trading History of Carole Ben-maimon
- 1
Carole Ben-maimon Trading Performance
GuruFocus tracks the stock performance after each of Carole Ben-maimon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carole Ben-maimon is 22.76%. GuruFocus also compares Carole Ben-maimon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carole Ben-maimon within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Carole Ben-maimon's insider trading performs compared to the benchmark.
Performance of Carole Ben-maimon
Average Return
-3.71%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.46 | 22.76 | 14.75 | -3.71 | -63.93 | -86.17 |
| Relative Return to S&P 500(%) | -1.3 | 19.64 | 7.52 | -13.5 | -80.04 | -99.06 |
Carole Ben-maimon Ownership Network
Ownership Network List of Carole Ben-maimon
Ownership Network Relation of Carole Ben-maimon
Carole Ben-maimon Owned Company Details
What does Larimar Therapeutics Inc do?
Who are the key executives at Larimar Therapeutics Inc?
Carole Ben-maimon is the director & President and CEO of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .
Larimar Therapeutics Inc (LRMR) Insider Trades Summary
Over the past 18 months, Carole Ben-maimon made 1 insider transaction in Larimar Therapeutics Inc (LRMR) with a net purchase of 5,000. Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 5,000 shares made by Gopi Shankar , and a net purchase of 5,000 shares made by Michael Celano .
In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 4,292,617 shares, with a net purchase of 4,292,617 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,310,367 shares were bought by its insiders, resulting in a net purchase of 4,310,367 shares.
Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Larimar Therapeutics Inc Insider Transactions
Carole Ben-maimon Mailing Address
Above is the net worth, insider trading, and ownership report for Carole Ben-maimon. You might contact Carole Ben-maimon via mailing address: C/o Impax Laboratories, Inc., 30831 Huntwood Avenue, Hayward Ca 94544.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
